Non-alcoholic fatty liver
Identifying PGC-1α-dependent hepatokines in a non-alcoholic fatty liver disease murine model
... Non-alcoholic fatty liver disease (NAFLD) has become a serious public health problem and is now considered as the major cause of liver disease ...of liver diseases starting with ...
82
Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts 1H-NMR Spectroscopy
... of non-alcoholic fatty liver disease (NAFLD) as well as of the frequency of Hepato-Cellular Carcinoma (HCC) associated with ...distant Non-Tumoral Tissue (NTT) collected from patients ...
18
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment
... Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 ...regulating liver micro- and macrovesicular steatosis and inflammation, independently from ...
11
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
... organoids; liver-on-a-chip; cell culture 1. Introduction Non-alcoholic fatty liver disease (NAFLD) comprises two histological forms: non- alcoholic fatty ...
19
Specificities of Hepatocellular Carcinoma Developed on Non Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue 1H-NMR Spectroscopy
... in Non Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue 1 H-NMR Spectroscopy 1 CHU Clermont-Ferrand, Service d’Hépato-gastroentérologie, F-63000 Clermont-Ferrand, ...
2
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials
... Figure 2 Results of meta-analyses: overall estimates and estimates obtained in specific study populations: (A) anthropometric variables and BMI, (B) glucose homeostasis, (C) liver enzymes. (X-axis) Absolute ...
13
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
... for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease ...groups: non-cannabis users (98.04%), non-dependent cannabis users ...and non- ...
17
Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease
... affects liver function. Non-alcoholic fatty liver disease (NAFLD) is the most common etiology of chronic liver disease affecting 25% of the general population worldwide(1) and ...
56
en fr Progression and diagnostic methods in non-alcoholic fatty liver disease Progression et tests diagnostiques de la stéatose hépatique non alcoolique
... against liver biopsy, neither compared head-to-head in a single ...The Fatty Liver Index has been developed in a cohort of patients from the general population with ultrasound- diagnosed hepatic ...
181
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
... the liver through regulation of the expression of enzymes involved in the transamination and deamination of amino acids and urea synthesis, which correlates with a modulation of the plasma urea concentration [ 256 ...
54
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
... (muscles, liver, pancreatic ß-cells) leads to the synthesis of specific lipids, such as sphingolipids (SL) which interfere with insulin ...of fatty acids from adipocytes into the ...of fatty acids to ...
20
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
... the liver and kid- neys against the putative lipotoxic effects of specific intracellular NEFA or their oxidation products, as previously suggested [39] ...the liver and kidneys of respective GSDIa mouse ...
17
Intracellular lipids: an independent cause of liver injury and chronic kidney disease in non-alcoholic fatty liver disease-like context
... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ...
2
Rôle du régulateur du cycle cellulaire p16INK4a dans le développement du diabète de type 2 et dans les maladies métaboliques du foie gras ou NAFLD (Non-Alcoholic Fatty Liver Disease) : rôle de p16INK4a dans le contrôle de la néoglucogenèse hépatique et dans le développement de la stéatose hépatique non alcoolique.
... Studies by the enCODE group based on a GWAS have also implicated the 9p21.3 risk region as a risk factor for abdominal aortic aneurysms, intracranial aneurysms and stroke (2).This locus is also associated with other ...
117
View of Non Alcoholic Fatty Liver Disease and Non Alcoholic Steato-Hepatitis are Multisystemic Diseases: Review for Intensivists
... est non invasive, économique, sans risque mais peu ...ou non de la présence de ...diagnostic non invasif de la fibrose hépatique et de la cirrhose et de plus permet de diagnostiquer la NASH mais ...
12
Pathogenic role of IL-15 in non-alcoholic fatty liver disease
... 2006). Liver cells are classified into two main groups: epithelial cells and mesenchymal ...the liver parenchyma (Papoulas, ...Hepatic non-parenchymal cells include endothelial cells, Kupffer cells ...
101
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
... chronic liver disease, complicated cirrhosis, or received putative antifibrotic treatment in the past 6 ...months. Liver biopsies were performed at Taleghani Hospital in 2012-2013 using a Meghini 16swg ...
40
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
... summary: Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent condition that can be optimally managed ...
8
Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.
... These fatty liver indexes are simple clinical tools for evaluating the extent of liver fat and they are predictive of incident ...with fatty liver. Background ...
10
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
... of Non-Alcoholic Fatty Liver Disease in the DIACART Cohort The analyses performed in the CERADIAB cohort were repli- cated in the DIACART cohort composed of 149 type 2 diabetic patients of ...
17